THE GLEBELAND SURGERY
THE GLEBE, BELBROUGHTON, STOURBRIDGECHD005
The percentage of patients with coronary heart disease with a record in the preceding 12 months that aspirin, an alternative anti-platelet therapy, or an anti-coagulant is being taken
Indicator | Year | Numerator | Denominator | Ratio | Centile |
---|---|---|---|---|---|
CHD 9 | 2005 | 107 | 115 | 93.0% | |
CHD 9 | 2006 | 110 | 114 | 96.5% | |
CHD 9 | 2007 | 115 | 121 | 95.0% | |
CHD 9 | 2008 | 122 | 132 | 92.4% | |
CHD 9 | 2009 | 118 | 127 | 92.9% | |
CHD 9 | 2010 | 121 | 130 | 93.1% | |
CHD 9 | 2011 | 112 | 124 | 90.3% | |
CHD 9 | 2012 | 111 | 121 | 91.7% | |
CHD 9 | 2013 | 120 | 130 | 92.3% | |
CHD005 | 2014 | 130 | 131 | 99.2% | |
CHD005 | 2015 | 126 | 131 | 96.2% | |
CHD005 | 2016 | 127 | 129 | 98.4% | |
CHD005 | 2017 | 121 | 125 | 96.8% | |
CHD005 | 2018 | 124 | 127 | 97.6% | |
CHD005 | 2019 | 135 | 138 | 97.8% | |
CHD005 | 2020 | 136 | 138 | 98.6% | |
CHD005 | 2021 | 136 | 138 | 98.6% | |
CHD005 | 2022 | 135 | 138 | 97.8% | |
CHD005 | 2023 | 145 | 148 | 98.0% |